Clinical Differentiation of Gilbert Syndrome, Crigler-NajjarSyndrome and β-Thalassemia Trait

Abstract

Unconjugatedhyperbilirubinemia in adolescents and young adults has to be differentiated clinically as it is associated with different clinical presentation , most commonly Gilbert syndrome (GS) – a benign hereditary bilirubin conjugation defect – versus increased bilirubin production from mild hemolytic disorders such as β-thalassemia trait, with the rare Crigler-Najjar syndromes as important considerations . This publication is made to educates clinicians and medical students. Basic laboratory tests and clinical clues will be important. Liver function tests (LFTs) and hemolysis markers (complete blood count, reticulocyte count,lactate dehydrogenase, etc.), followed by targeted tests such as hemoglobin electrophoresis for hemoglobinopathies and provocative tests (fasting or rifampicintest, phenobarbital trial) for conjugation defects We emphasize how inexpensive investigations can confirm the diagnosis, avoiding unnecessary costly workups.Key distinguishing features of GS, Crigler-Najjar type 2, and β-thalassemia trait – including typical bilirubin levels, hematologic indices, genetic basis, andmanagement – are summarized in a comparative table. Early recognition of these benign conditions is crucial for patient reassurance, appropriate counseling(e.g. for carrier traits), and preventing unwarranted interventions.

To distinguish Gilbert syndrome, Crigler-Najjar (type 2), and β-thalassemia trait, one should understand the clinical and laboratory profile of each: